Skip to main content
. 2020 Nov 24;2020:8886073. doi: 10.1155/2020/8886073

Table 2.

The comparison between cases with and without improvement of bowel preparation.

Improved BP Non-improved BP p value
Case number 77 (72.6) 29 (27.4)
Gender, n (%), male : female 40 : 37 (51.9 : 48.1) 16 : 13 (55.2 : 44.8) 0.77
Age, mean ± SD 68.7 ± 9.8 71.6 ± 8.6 0.08
Age, n (%), ≤74 : ≥75 years old 50 : 27 (64.9 : 35.1) 18 : 11 (62.1 : 37.9) 0.94
Body mass index, mean ± SD 23.2 ± 3.8 23.6 ± 4.2 0.36
Performance status (0 : 1 + 2), n (%) 71 : 6 (92.2 : 7.8) 21 : 8 (72.4 : 27.6) 0.01
Laxative combination, n (%)
Irritant laxative, n (%)
25 (32.5)
14 (18.2)
10 (44.4)
9 (29.6)
0.84
0.15
Dose of PEG/day (13.7 g : 27.4 g), n (%) 68 : 9 (88.3 : 11.7) 26 : 3 (89.7 : 10.3) 0.88
Colonoscopy
 Cecal intubation, n (%) 77 (100) 29 (100) 1.0
 Insertion time (min), mean ± SD 8.3 ± 6.4 9.2 ± 7.5 0.03
 Pain score, mean ± SD 0.4 ± 0.8 0.6 ± 0.9 0.02
Underlying disease
 Hyperlipidemia, n (%) 23 (29.9) 9 (31.0) 0.90
 Colorectal surgery, n (%) 14 (18.2) 2 (6.9) 0.25
 Diabetes 10 (13.0) 3 (10.3) 0.97
 Hypothyroidism 4 (5.2) 1 (3.4) 0.89
 Hepatic or biliary disorder 4 (5.2) 0 (0.0) 0.49
 Parkinson's disease 0 (0.0) 1 (3.4) 0.60
Concomitant medication
 Antacids, n (%) 20 (26.0) 8 (27.6) 0.86
 Calcium antagonists, n (%) 21 (27.3) 7 (24.1) 0.74
 Antidepressants, n (%) 8 (10.4) 6 (20.7) 0.28

BP: bowel preparation; SD: standard deviation; PEG+E: polyethylene glycol plus electrolytes; pain score (0: no pain, 1: minimum pain, 2: moderate pain, and 3: severe pain).